Whole-exome sequencing (WES) has facilitated the discovery of genetic lesions underlying monogenic disorders. Incomplete penetrance and variable expressivity suggest a contribution of additional genetic lesions to clinical manifestations and outcome. Some monogenic disorders may therefore actually be digenic. However, only a few digenic disorders have been reported, all discovered by candidate gene approaches applied to at least one locus. We propose here a novel two-locus genome-wide test for detecting digenic inheritance in WES data. This approach uses the gene as the unit of analysis and tests all pairs of genes to detect pairwise gene x gene interactions underlying disease. It is a case-only method, which has several advantages over classic case-control tests, in particular by avoiding recruitment and bias of controls. Our simulation studies based on real WES data identified two major sources of type I error inflation in this case-only test: linkage disequilibrium and population stratification. Both were corrected by specific procedures. Moreover, our case-only approach is more powerful than the corresponding case-control test for detecting digenic interactions in various population stratification scenarios. Finally, we validated our unbiased, genome-wide approach by successfully identifying a previously reported digenic lesion in patients with craniosynostosis. Our case-only test is a powerful and timely tool for detecting digenic inheritance in WES data from patients.
Abstract. Whole-exome sequencing (WES) has facilitated the discovery of genetic lesions underlying monogenic disorders. Incomplete penetrance and variable expressivity suggest a contribution of additional genetic lesions to clinical manifestations and outcome. Some monogenic disorders may therefore actually be digenic. However, only a few digenic disorders have been reported, all discovered by candidate gene approaches applied to at least one locus. We propose here a novel two-locus genome-wide test for detecting digenic inheritance in WES data. This approach uses the gene as the unit of analysis and tests all pairs of genes to detect pairwise gene x gene interactions underlying disease. It is a case-only method, which has several advantages over classic case-control tests, in particular by avoiding recruitment and bias of controls. Our simulation studies based on real WES data identified two major sources of type I error inflation in this case-only test: linkage disequilibrium and population stratification. Both were corrected by specific procedures. Moreover, our case-only approach is more powerful than the corresponding case-control test for detecting digenic interactions in various population stratification scenarios. Finally, we validated our unbiased, genome-wide approach by successfully identifying a previously reported digenic lesion in patients with craniosynostosis. Our case-only test is a powerful and timely tool for detecting digenic inheritance in WES data from patients.
Significance statement. Despite a growing number of reports of rare disorders not fully explained by monogenic lesions, digenic inheritance has been reported for only 54 diseases to date. The very few existing methods for detecting gene x gene interactions from nextgeneration sequencing data were generally studied in rare-variant association studies with limited simulation analyses for short genomic regions, under a case-control design. We describe the first case-only approach designed specifically to search for digenic inheritance, which avoids recruitment and bias related to controls. We show, through both extensive simulation studies on real WES datasets and application to a real example of craniosynostosis, that our method is robust and powerful for the genome-wide identification of digenic lesions.
INTRODUCTION
for interaction, particularly in the context of GWAS (29) (30) (31) (32) (33) . Our novel approach is based on 48 the aggregation of rare variants within a gene as the unit of analysis, overcoming the lack of 49 power inherent to studies of rare variants. It also greatly decreases the computer time required for interaction analyses, by testing pairwise combinations at the gene level. 
MATERIAL AND METHODS

53
The variant aggregation model 54 A strategy commonly used for low-frequency variants from NGS data involves tests 55 based on the aggregation of variants within a genomic region. Several types of tests are used 56 for this purpose: burden tests, adaptive burden tests, variance-component tests and 57 combinations of these three classes (34) . Here, we propose a method based on the classic 58 collapsing of variants within the unit of a gene. This approach optimizes statistical power 59 under a hypothesis of genetic homogeneity, whilst making it possible to assess actual gene x 60 gene interactions with a number of tests corresponding to the number of possible two-way 61 combinations of genes. In this study, the aggregation of variants within a gene is based on the 62 methodology of a class of burden tests known as the "cohort allelic sums test" (CAST).
63
Formally, for each gene and a given subset of variants observed within this gene, if n is 64 the number of individuals studied, we consider the following vector ( 1 , … , ) denoted
. For each = 1, … , , is then defined as follows:
The term "carries" depends here on the biological inheritance model. For example, in a 68 dominant model, = 1 if individual i harbors at least one copy of at least one variant allele 69 from the set of variants studied within gene j. In addition, the choice of may be based on 70 different features at the variant level, such as the MAF or functional impact prediction, as 71 described below.
72
The case-control design for interaction Using this notation, data for genes and in a case-control dataset, with a binary 74 disease status D, can be summarized into two 2x2 contingency tables, one for affected 75 individuals (cases, D=1) and one for unaffected individuals (controls, D=0), as in Table 1 .
76
Based on these tables, let = ( ,00 , , .
82
Classic statistical analyses of interaction are based on the comparison of and .
83
More specifically, the following classic case-control logistic regression model is often used to 84 test for interaction:
where it can be shown that the interaction coefficient, equals log ( ). This model also 87 takes main effects into account, by considering coefficient terms for each gene ( and ). In Subsequently, the null hypothesis of no interaction = 0 can be tested in a likelihood ratio 93 test (LRT) with one degree of freedom, in the presence or absence of main genetic effects 94 and/or covariate effects.
95
The case-only model 96 Interactions can also be assessed by focusing exclusively on cases, such that all the 97 information is provided by the 2x2 contingency table for affected individuals (Table 1 ). In 98 this situation, the standard full logistic regression model to test for interaction between genes 99 G k and G j is now written as
where is equal to log( ), is a matrix of covariates and a vector of coefficients. As 102 before, a LRT can be used to test the null hypothesis = 0.
103
Under the assumption that vectors G k and G j are not correlated, implying, in particular, that 104 variants of the two genes are not in linkage disequilibrium (LD), a deviation from 1 of 105 indicates interaction. In addition, if the disease is rare, is close to 1, and, consequently, observed at = 5% (Table S1 ). We hypothesized that this inflation might be at least partly 180 due to the small sample sizes in the contingency cells of Table 1 . We tested this hypothesis by 181 repeating the analyses for both the case-only and the case-control tests with more common 182 variants and a larger number of carriers at the gene level (i.e., variants with a MAF < 10% and 183 genes with carriage rates of at least 25%, and variants with a MAF < 15% and genes with 184 carriage rates of at least 35%; Table 2 ). The type I error was clearly lower, and improved as 185 the frequency of variants increased. For both tests, empirical type I errors were within the 186 boundaries of the confidence interval for = 0.1%, but remained slightly above the upper 187 limit of this interval for = 5% (Table S1 ).
Sample size investigation.
We investigated the impact of contingency cell sample sizes 189 and the number of tests on the case-only approach, by extending the previous scenario to two 190 new settings with less stringent MAF thresholds. First, we conducted a case-only test for all 191 genes carried by at least 5% rather than 15% of individuals in the IBS+TSI population. This 192 strategy increased the number of genes retained to 5,563, and, after the removal of genes in 193 LD, we tested a total of 15,465,141 pairs of genes and generated the QQ-plot for SI 194 Appendix, Fig. S3 . The type I error was moderately inflated (0.057) for = 5% and there was 195 a slightly conservative type I error value (0.00085) for = 0.1% (Table S3 ). Finally, we 196 simulated the data for one gene considered "rare" (at least 1% carriers, total of 11,470 genes) value line (Fig. 4 ). This result (p = 1.5810 -6 , OR = 30.95) corresponds to the digenic 274 combination of SMAD6 and rs1884302, and is one order of magnitude higher than the second 275 result (p = 1.0410 -5 ), which is close to the expected line. The 2x2 contingency table for the 276 top result is shown in Table S5 , and corresponds to the distribution found in the original paper 277 (20) . Thus, the two-locus genome-wide analysis focusing on genes harboring rare variants 278 together with the potential contribution of a common modifier variant was able to detect the 279 previously reported DI for craniosynostosis (20) . This analysis provides proof-of-concept that 280 our statistical test can detect DI without the need for biological assumptions concerning the 281 disease studied, even when the disease is very rare. 
DISCUSSION
There is increasing evidence to suggest that DI plays an important role in the genetic 285 architecture of many conditions. The three previously reported approaches searching for gene 286 x gene interactions in the general context of rare variant association studies are based on case-287 control designs (26) (27) (28) . Moreover, these tests were assessed in limited simulation studies 288 involving short genomic sequences of less than 500 variants (n=1) or only 20 variants (n=2), 289 and were not based on WES-based simulated data. None was reported to have detected two 290 genetic lesions at the GW level. Indeed, all previously successful DI studies relied on 291 candidate gene approaches to overcome the lack of appropriate statistical resources to search 292 for DI at the GW level (17) . DI studies and statistical interaction approaches have thus been 293 following separate paths. We show here, through both extensive simulation studies on real 294 WES datasets and application to the example of craniosynostosis, that our method is robust 295 and powerful for the identification of digenic lesions at the GW level. Our unbiased genetic 296 confirmation of the reported digenic lesions in the craniosynostosis dataset composed only of 297 exome data from cases, a common feature of real datasets for rare disorders, justifies the 298 choice of a case-only test based on the aggregation of rare variants. Further strong support for 299 this approach is provided by the higher overall power for the case-only approach than for the 300 corresponding case-control test, as shown here, for the same number of cases. We present 301 here the results for cohorts of at least 200 cases. We recommend using at least 100 cases to 302 ensure sufficient statistical power, but this is not an absolute requirement as it depends on the 303 proportion of double carriers among cases (strength of the genetic association).
304
The proposed methodology is simple to apply and flexible. It requires only the 305 definition of a set of variants for testing, with filters based on features including MAF, variant 306 annotations, and genetic models, defined before the analysis. It can, of course, be used at the 307 gene level for the two loci studied. It can also directly assess the role of common variants as 308 potential modifiers of a known monogenic defect. This assessment is achieved by simply replacing the gene by the variant as the unit of analysis, as illustrated in the craniosynostosis 310 example. Our result also provide proof-of-concept that incomplete penetrance in disorders 311 considered to be monogenic can be explained by a unique digenic combination. The 312 frequency of carriers considered in our simulation studies may appear to be too high, but two 313 important points must be taken into account when studying a rare disorder. First, these 314 thresholds correspond to a cumulative frequency of the variants potentially contributing to the Power curves are presented as in Figure 1 . Results are shown for the analysis of one "common" (AHNAK) and one "rare" gene (MPC1) (scheme 2GR Non carriers Note: Boundaries of the 95% confidence intervals are shown in brackets. Type I error values lying outside the 95% confidence interval's boundaries are in italic. a All pairs of genes with >15% of carriers of variants with MAF<5%. b Pairs of genes as Pg 0 but with genes apart by at least 2 Mb. c Pairs of genes as Pg 2 with adjustment on the first three principal components. d Pairs of genes as Pg 2 with >25% of carriers of variants with MAF<10%. e Pairs of genes as Pg 2 with >35% of carriers of variants with MAF<15%. Note: Boundaries of the 95% confidence intervals are shown in brackets. Type I error values lying outside the 95% confidence interval's boundaries are in italic. a Using pairs of genes with genes apart by at least 2 Mb. 
